STEREOSELECTIVE RENAL TUBULAR SECRETION OF QUINIDINE AND QUININE

被引：68

作者：

NOTTERMAN, DA

DRAYER, DE

METAKIS, L

REIDENBERG, MM

机构：

[1] CORNELL UNIV,MED CTR,COLL MED,DEPT PHARMACOL,1300 YORK AVE,NEW YORK,NY 10021

[2] CORNELL UNIV,MED CTR,COLL MED,DEPT MED,NEW YORK,NY 10021

[3] CORNELL UNIV,MED CTR,COLL MED,DEPT PEDIAT,NEW YORK,NY 10021

[4] NYU,SCH MED,DEPT PEDIAT,NEW YORK,NY 10003

来源：

关键词：

D O I：

10.1038/clpt.1986.216

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：511 / 517

页数：7

共 19 条

[1] Ariens E.J., 1983, STEREOCHEMISTRY BIOL, P11
[2] ARIENS EJ, 1983, STEREOCHEMISTRY BIOL
[3] Benet L.Z., 1984, PHARMACOKINETIC BASI, P12
[4] AGE AND RENAL CLEARANCE OF CIMETIDINE
DRAYER, DE
ROMANKIEWICZ, J
LORENZO, B
REIDENBERG, MM
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (01) : 45 - 50
[5] CLINICAL CONSEQUENCES OF THE LIPOPHILICITY AND PLASMA-PROTEIN BINDING OF ANTIARRHYTHMIC DRUGS AND ACTIVE METABOLITES IN MAN
DRAYER, DE
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1984, 432 (DEC) : 45 - 56
[6] DRAYER DE, 1986, DRUG PROTEIN BINDING, P332
[7] GOLDSTEIN A, 1974, PRINCIPLES DRUG ACTI, P160
[8] HEWITT WR, 1983, PROG DRUG METAB, V7, P11
[9] JAHNCHEN E, 1983, TOP PHARM SCI, P109
[10] JENNER P, 1973, DRUG METAB REV, V2, P117